Prevalence of intestinal parasites among HIV/AIDS patients attending Infectious Disease Hospital Kano, Nigeria. 2014

Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
Family Health International (FHI 360), Nigeria.

BACKGROUND Intestinal parasitic infection has been a major source of morbidity in tropical countries especially among HIV patients. The aim of this study was to determine prevalence of intestinal parasites and its association with immunological status and risk factors among HIV infected patients in Kano, Nigeria. METHODS 105 HIV+ subjects and 50 HIV- controls were recruited into the studies from June to December 2010. Clinical information was collected using a questionnaire. Single stool and venous blood samples were collected from each subject. Stool examination and CD4+ count were performed. RESULTS Prevalence of intestinal parasites was 11.4% and 6% among the HIV+ and control subjects respectively with no statistically significant difference (p = 0.389). Specifically, the following intestinal parasites were isolated from HIV+ subjects: Entamoebahistolytica (5.7%), hookworm (3.8%), Entamoeba coli (1%), Blastocystishominis (1%). Only Entamoebahistolytica was isolated among the control subjects. The mean CD4+ count of HIV+ and control subjects was 287 cells/ul and 691 cells/µl respectively while the median was 279(Q1-120, Q3-384) cell/µl and 691(Q1-466, Q3-852) cell/µl respectively with statistically significant difference (P= 0.021). Diarrhea and the absence of anti-parasitic therapy seem to be important risk factors associated with the occurrence of intestinal parasites among HIV+ subjects. A higher prevalence (14.5%) of intestinal parasites was observed in subject with CD4+ count 350 cell/µl. CONCLUSIONS Routine examination for intestinal parasites should be carried out for better management of HIV/AIDS patients.

UI MeSH Term Description Entries
D007411 Intestinal Diseases, Parasitic Infections of the INTESTINES with PARASITES, commonly involving PARASITIC WORMS. Infections with roundworms (NEMATODE INFECTIONS) and tapeworms (CESTODE INFECTIONS) are also known as HELMINTHIASIS. Parasitic Intestinal Diseases,Disease, Parasitic Intestinal,Diseases, Parasitic Intestinal,Intestinal Disease, Parasitic,Parasitic Intestinal Disease
D008297 Male Males
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006761 Hospitals Institutions with an organized medical staff which provide medical care to patients. Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
January 2009, Journal of epidemiology,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
January 2005, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
January 2011, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
January 2006, The Malaysian journal of medical sciences : MJMS,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
October 2011, North American journal of medical sciences,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
January 2020, Human antibodies,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
February 2013, AIDS research and therapy,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
January 2014, The Pan African medical journal,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
September 2005, African health sciences,
Ebenezer Feyisayo Jegede, and Esther Tinuade Ibijoke Oyeyi, and ArmaYau Hamisu Bichi, and Henry Akwen Mbah, and Kwasi Torpey
March 2014, African health sciences,
Copied contents to your clipboard!